Innovative molecular imaging instrument launched to provide new insights into drug discovery and cell biology

NPL has launched the 3D OrbiSIMS – a new molecular imaging technology with the highest reported simultaneous spatial and mass resolutions. Such high performance is essential to reveal the biomolecular complexity in a single cell. The new technology is reported in a Nature Methods paperpublished this week. NPL's Prof Ian Gilmore and Yulia Panina, PhD student at [...]

Scipio bioscience Announces Its Seed Funding

PARIS---Scipio bioscience, a Paris-based biotechnology company devoted to providing a novel sample preparation solution for single-cell studies in the form of benchtop kits, announces today the completion of its initial fundraising. A total of €1.2m has been obtained from two European seed funds: Paris, France-based Seventure Partners’ Quadrivium I seed fund and Bonn, Germany-based High-Tech [...]

Fluxion Biosciences Appoints Harvard Bioscience as North American Distributor

SAN FRANCISCO -- Fluxion Biosciences, a leading developer of automated solutions for cellular analysis in life sciences research and drug discovery, today announced that it has signed a distribution agreement with Harvard Biosciences. The https://www.baratron.com/ - photo distribution agreement covers Fluxion's BioFlux™ and IonFlux™ platforms for sale to Harvard Bioscience's customers in North America. Fluxion's BioFlux system is [...]

LGC Genomics strengthens leadership team to support the launch of new NGS business unit

LGC, the international life sciences company, today announced that it has appointed Emma Millican as Global NGS Business Unit Manager and Dr. Harold Swerdlow as Head of NGS Technology Development for their recently established Next Generation Sequencing Business Unit as part of their expanding Genomics division. These appointments further strengthen LGC’s in-house expertise to help drive [...]

Horizon Discovery’s Dharmacon introduces Edit-R CRISPRa reagent platform for genome-wide CRISPR activation

First-to-market reagents enable native gene overexpression for meaningful gain-of-function studies Available in multiple formats to support a wide range of applications   Cambridge, UK: Horizon Discovery (LSE: HZD) (“Horizon” or the “Company”), a global leader in gene editing and gene modulation technologies, today announced the launch of its reagent platform for CRISPR activation (CRISPRa) from its recently [...]

GNA Biosolutions Reveals New Ultrafast PCR Platform at Medica

Groundbreaking nucleic acid detection technology using nanomaterials DUESSELDORF – GNA Biosolutions GmbH, a molecular technology company based in Martinsried, Germany, today announced the launch of Pharos V8, the world’s first Laser PCR® platform. Pharos V8, an ultrafast PCR instrument for in vitro research use, will be showcased at the Medica Trade Fair (Exhibition Hall 3, Booth E93) from November 13-16. [...]

New CRISPR Kits Simplify Gene Editing

ST. LOUIS -- Canopy Biosciences™, LLC, a provider of technologies for gene editing and personalized medicine, announced today that it has launched CRISPR Complete Gene Editing Kits. The CRISPR Complete Kits are the most comprehensive CRISPR kits available, including everything a researcher needs to perform gene editing with the CRISPR-Cas9 system. CRISPR-Cas9 has revolutionized the field of [...]

QIAGEN celebrates surpassing 2,000 cumulative placements of QIAsymphony

Outstanding and unmatched capabilities fuel strong growth in installed base and consumables use on highly versatile Sample to Insight automation solution Hilden, Germany, and Germantown, Maryland – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the 2,000th placement of QIAsymphony, the leading Sample to Insight workflow automation solution for molecular laboratories worldwide. The milestone [...]

SCIEX Announces Joint Venture with Zhenjang Dian Diagnostics in China

Leading Diagnostics Companies Combine to Address Diagnostic and Wellness Testing in China Framingham, MA and Shanghai, CN — SCIEX Dignostics, the in vitro diagnostics (IVD) division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today that it has formed a joint venture (JV) with Zhejiang Dian Diagnostics (Dian), a leader in the [...]

STRECK ANNOUNCES NEW MEMBERS OF LEADERSHIP TEAM

Streck announces the appointment of five new members of the leadership team. Chris Connelly, Ph.D., was named Director of Research and Development – New Product Development/Molecular. Dr. Connelly joined Streck in 2010 and was previously R&D Scientific Manager for the Molecular Division and R&D Scientist for hematology and stabilization products. He earned a bachelor’s degree [...]

Access IBO on Knowledge Center